Rivastigmine Tartrate (Breckenridge Pharmaceutical, Inc)
Welcome to the PulseAid listing for the Rivastigmine Tartrate drug offered from Breckenridge Pharmaceutical, Inc. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Breckenridge Pharmaceutical, Inc |
| NON-PROPRIETARY NAME: | Rivastigmine Tartrate |
| SUBSTANCE NAME: | RIVASTIGMINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-06-13 |
| END MARKETING DATE: | 0000-00-00 |
Rivastigmine Tartrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rivastigmine Tartrate from Breckenridge Pharmaceutical, Inc |
| LABELER NAME: | Breckenridge Pharmaceutical, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/1) |
| START MARKETING DATE: | 2012-06-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51991-793_a41cadb5-ffcf-42ce-9e20-a5d99eaf30e4 |
| PRODUCT NDC: | 51991-793 |
| APPLICATION NUMBER: | ANDA091689 |
Other RIVASTIGMINE TARTRATE Pharmaceutical Manufacturers / Labelers:
